September 30, 2014 4:19 PM ET


Company Overview of Immunovative Therapies Ltd.

Company Overview

Immunovative Therapies Ltd., a biopharmaceutical company, develops products to treat adult patients in Israel. It specializes in the development of immunotherapy drug products that incorporate living immune cells as active ingredients for the treatment of cancer and infectious disease. Its products include AlloStim, which contains activated T-Stim cells that are formulated for infusion; CryoStim, an in-situ therapeutic cancer vaccine for patients with disseminated metastatic tumors; and AlloVax, an individualized anti-cancer vaccine to educate the immune system during the period of cancer remission to prevent the tumor from recurring. The company develops protocols for patients with various ...

P.O. Box 974

Shoham,  60850


Founded in 2004


972 3 970 2090

Key Executives for Immunovative Therapies Ltd.

Founder and Chief Executive Officer
Chairman of Immunovative Inc and Chief Executive Officer of Immunovative Inc
Age: 44
Chairman of Immunovative
Age: 35
Chairman of the Scientific Advisory Board
Director of Regulatory Affairs and Clinical Operations
Compensation as of Fiscal Year 2014.

Immunovative Therapies Ltd. Key Developments

Immunovative, Inc. Enters into Settlement Agreement with Immunovative Therapies Ltd

On January 14, 2013, Immunovative Inc. received a notice from Immunovative Therapies Ltd. purporting to terminate the license agreement dated December 9, 2011 between the company and Immunovative Therapies Ltd. On January 16, 2013, the company filed an action against Immunovative Therapies Ltd. in the United States District Court of the Southern District of New York alleging various damages and seeking injunctive relief against Immunovative Therapies Ltd. On February 19, 2013, solely to avoid the costs, risks and uncertainties inherent in litigation, and without admitting any liability, breach, or wrongdoing, the company entered into a Settlement Agreement and Release with Immunovative Therapies Ltd. The Settlement Agreement resolves all claims brought by the company against Immunovative Therapies Ltd., will result in the company dismissing its claims against Immunovative Therapies Ltd. with prejudice and will prevent Immunovative Therapies Ltd. from bringing any counterclaims against the company. As part of the Settlement Agreement, Immunovative Therapies Ltd. has agreed to provide the company an immaterial cash payment and grant the company a 9% equity interest in Immunovative Therapies Ltd.

Immunovative, Inc. Files Lawsuit Against Immunovative Therapies Ltd

Immunovative Inc. announced that the company has filed a lawsuit against Immunovative Therapies Ltd. in the U.S. District Court for the Southern District of New York. The lawsuit alleges that ITL wrongfully terminated the License Agreement between ITL and the company. The suit seeks the imposition of an equitable lien on with respect to the patents, intellectual property, and scientific work funded by the company. In the alternative, the suit seeks return of approximately $3.7 million paid by the company to ITL to fund its scientific work, compensatory damages, and an equity interest in ITL as provided by the License Agreement.

Immunovative, Inc. Announces Termination of License Agreement with Immunovative Therapies Ltd

Immunovative Inc. announced that on January 8, 2013, it received from Immunovative Therapies Ltd. a notice that purports to terminate effective immediately the license agreement dated as of December 9, 2011, between the company and ITL. The notice alleges numerous purported breaches of the license agreement, mainly with respect to the administration and timing of payments from the company to ITL. It also demands immediate payment of approximately $4.15 million from the company to ITL for what it claims to be damages suffered by ITL.

Similar Private Companies By Industry

Company Name Region
NeuroQuest Middle East/Africa
BrainWatch Ltd. Middle East/Africa
CBD Technologies, Ltd. Middle East/Africa
Hapto Biotech (Israel) Ltd Middle East/Africa
Biosight Ltd. Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immunovative Therapies Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at